Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial

BACKGROUND: The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 trial demonstrated a 39% reduction in HIV infection, with a 54% HIV reduction in women who used tenofovir gel consistently. A confirmatory trial is expected to report results in early 2015. In the interim, we hav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Mansoor, Leila E, Abdool Karim, Quarraisha, Mngadi, Kathryn T, Dlamini, Sarah, Montague, Carl, Nkomonde, Nelisiwe, Mvandaba, Nomzamo, Baxter, Cheryl, Gengiah, Tanuja N, Samsunder, Natasha, Dawood, Halima, Grobler, Anneke, Frohlich, Janet A, Abdool Karim, Salim S
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300828/
https://ncbi.nlm.nih.gov/pubmed/25527071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-496
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados